Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814037-151828488	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 66.2;intestine: 81.7;liver: 123.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 610.4"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7"	"Not detected"	"Not detected"							HPA002911	Approved					NA	NA					"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	3.9	66.2	0.1	0.1	1.6	0.0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0.0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0.0	0.1	1.7	0.2	0.3	0.0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.5	0.2	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.2	6.4	0.0	0.1	0.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.2	1.4	0.3	0.2	0.4	2.1	0.0	2.3	0.2	1.9	0.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	2.4	1.4	0.0	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	11.0	0.0	0.0	0.2	0.0	1.1	58.6	4.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.2	0.0	0.0	610.4	0.2	0.0	0.0	3.7	10.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.0	0.1
ABHD12	"ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106"	ENSG00000100997	"Abhydrolase domain containing 12"	Q8N2K0	20	25294743-25390983	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Cataract, Deafness, Disease mutation, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026866	Uncertain					NA	NA					"HPA026866: AB_1844446"	"prognostic unfavorable (3.81e-5)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.32e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (8.51e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.11e-3)"	11.3	13.4	27.4	10.0	32.1	9.8	10.4	22.3	39.8	11.1	15.6	30.8	14.1	20.7	9.1	58.9	20.4	11.3	14.0	12.2	41.5	25.9	18.9	13.1	14.0	10.3	31.5	21.0	13.8	65.6	16.0	14.4	25.6	26.9	15.6	15.2	11.5	13.8	17.4	4.0	16.2	21.1	9.9	43.3	7.8	22.1	7.6	19.0	10.2	36.8	7.9	16.0	15.7	10.9	3.9	14.6	12.6	14.2	11.1	11.5	6.0	14.9	34.2	8.8	11.1	18.1	10.8	21.8	21.5	18.0	16.9	19.5	20.0	22.9	4.7	12.2	16.9	40.3	24.3	11.2	12.8	14.4	4.9	9.0	7.6	9.4	27.7	14.4	7.3	16.2	13.5	8.4	20.8	9.9	20.6	7.7	8.8	5.5	71.7	16.0	30.9	11.0	7.7	6.8	18.5	21.7	8.5	22.7	44.7	11.4	31.1	11.3	9.5	18.1	44.7	31.8	16.4	15.1	12.5	9.6	21.4	14.5	13.0	12.4	8.4	7.8	7.5	14.9	8.7	13.7	9.8	14.2	12.6	8.0	12.2	6.4	3.1	8.8	11.5	14.6	3.9	7.5	7.4	1.8	11.1	13.1	13.1	7.9	6.0	27.4	32.1	22.3	39.8	41.5	25.9	31.5	21.0	26.9	19.0	6.0	6.2	9.7	26.7	15.8	33.4	14.0	38.2	10.7	9.1	26.2	9.8	77.6	23.2	30.2	42.1	13.8	92.3	0.0	29.7	81.1	22.7	35.8	10.3	16.1	103.4	39.7	32.6	11.6	27.2	80.7	15.0	39.8	32.1	91.0	27.6	27.0	20.7	45.6	19.4	19.5	20.6	25.8	14.6	18.2	32.5	15.9	109.4	13.8	31.4	31.0
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6"	Q9BV23	3	58237506-58295693	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	8.3	10.0	11.6	4.6	14.0	1.0	5.8	17.7	22.5	3.7	8.1	30.0	10.3	26.3	4.7	10.8	4.8	6.9	4.4	4.1	19.0	9.2	24.3	43.4	6.3	5.2	18.6	12.2	4.1	2.4	4.8	15.2	4.8	19.0	4.4	8.1	10.5	3.0	12.9	3.1	17.2	33.5	6.8	24.0	22.8	9.0	3.1	14.3	2.0	6.6	2.1	5.4	4.6	4.1	3.9	7.0	2.1	9.3	0.7	2.6	1.1	2.0	7.7	1.1	5.0	14.5	2.6	13.4	5.4	4.8	5.7	7.7	4.0	2.8	3.9	0.5	2.9	17.6	6.0	5.2	2.4	5.1	6.6	2.6	3.3	5.2	5.5	4.9	1.0	17.6	2.5	11.1	5.2	2.5	6.7	3.2	6.5	3.9	9.0	4.6	1.5	6.7	0.4	3.7	16.7	17.0	2.5	2.3	8.7	8.7	2.8	6.7	2.7	5.9	3.3	11.1	2.3	2.2	2.7	3.4	4.1	4.5	10.1	6.4	2.6	7.6	0.1	10.5	9.9	5.6	0.0	2.8	2.1	2.1	9.3	2.0	3.9	1.2	2.6	4.6	3.0	1.2	1.5	0.0	0.7	6.2	7.0	1.4	1.1	11.6	14.0	17.7	22.5	19.0	9.2	18.6	12.2	19.0	14.3	0.0	2.6	8.8	2.6	7.7	13.8	4.8	0.0	17.4	5.7	3.5	3.9	2.2	1.7	2.9	0.8	7.8	13.6	0.0	1.6	0.4	2.1	1.3	10.5	53.3	8.1	14.3	0.0	26.4	14.6	0.4	6.4	9.6	3.3	14.4	2.2	10.8	1.6	0.0	7.8	15.4	3.0	0.0	3.5	0.5	2.3	21.5	0.5	3.2	4.5	2.0
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"		9	133061978-133071861	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	348	"pancreas: 1584.8"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 809.5"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 9.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.1	0.2	2.9	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	0.2	0.2	0.8	1584.8	0.0	4.5	0.2	0.2	0.2	0.0	0.2	0.2	4.5	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	1.6	0.2	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	4.2	2.6	1.4	1.0	4.2	0.8	0.5	0.6	0.8	1.2	0.8	1.2	2.0	0.8	0.7	2.9	0.9	7.8	0.2	2.5	1.6	2.1	0.5	2.7	0.6	0.9	7.9	2.1	5.1	0.7	0.5	1.8	0.8	9.9	1.3	1.0	0.7	1.7	1.2	4.1	6.9	0.9	1.3	2.3	1.2	0.9	0.5	3.6	7.2	1.7	0.9	0.9	0.4	6.3	1.3	3.7	0.6	2.0	2.6	2.3	0.5	0.5	4.2	1.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.2	2.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.7	0.0	0.7	1.6	2.5	0.0	0.0	0.0	0.0	0.1	3.3	1.7	0.2	0.0	3.3	0.0	809.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	11.8	0.0	1.1	42.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	1.2	1.7
DAGLA	"C11orf11, DAGLALPHA, KIAA0659, NSDDR"	ENSG00000134780	"Diacylglycerol lipase alpha"	Q9Y4D2	11	61680433-61747001	"Disease related genes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.0"	"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;intermediate monocyte: 1.9;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.2;T-47d: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062497, CAB078793"	Approved	Supported				NA	NA					"CAB078793: , HPA062497: AB_2684784"	"unprognostic (2.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.99e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-2)"	3.7	2.5	7.2	2.8	13.3	1.1	3.0	12.0	22.0	3.1	6.0	3.6	3.1	4.4	2.7	3.8	4.7	3.8	2.9	3.8	8.6	6.0	2.3	0.5	3.2	1.3	3.7	7.4	1.2	8.8	1.7	3.3	1.7	4.5	3.5	3.7	2.5	7.9	4.0	3.1	1.1	5.2	3.2	1.4	3.4	2.9	3.3	2.7	0.0	1.6	2.0	1.0	1.7	1.4	0.0	0.8	0.0	1.9	0.0	0.1	0.3	5.4	6.2	4.8	1.0	1.1	1.8	0.8	2.6	0.7	2.9	3.1	3.6	11.2	0.0	2.6	2.3	4.5	3.2	0.8	0.0	1.2	0.0	3.2	0.0	4.6	5.5	1.8	0.0	1.0	0.9	0.3	3.7	0.0	1.7	0.8	0.4	0.0	0.0	1.3	2.6	0.0	0.0	9.9	1.9	6.0	0.0	0.7	0.0	1.0	1.3	10.0	5.5	1.4	2.4	1.7	1.2	12.3	3.1	3.4	1.9	8.7	5.2	3.0	0.0	0.0	0.0	5.2	1.4	3.0	0.0	1.4	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.3	7.2	13.3	12.0	21.5	8.6	6.0	3.7	7.4	4.5	2.7	3.0	0.3	0.0	0.3	0.3	1.1	0.7	0.0	0.0	2.3	3.5	0.0	0.0	0.0	1.5	0.0	0.6	3.1	0.0	1.9	0.1	0.5	0.7	0.0	0.0	2.2	0.0	4.1	2.5	3.3	0.0	1.7	2.7	0.0	0.0	5.6	1.7	2.4	0.0	3.9	0.4	0.3	0.0	0.4	1.2	2.9	0.3	0.0	0.0	4.5	0.0
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	20.1	28.2	12.6	12.7	20.3	25.8	29.8	18.4	26.1	19.1	18.0	11.4	19.4	15.1	14.3	17.5	16.2	12.5	26.6	18.9	12.4	13.8	24.0	88.0	18.4	25.2	11.6	5.8	22.5	47.0	14.2	19.0	45.7	7.5	14.6	10.6	14.6	34.1	22.3	22.0	22.1	31.3	16.0	13.2	15.1	14.0	27.1	7.9	7.2	23.1	15.1	16.8	15.6	20.8	5.6	18.9	13.6	14.7	2.4	8.4	7.5	10.9	12.5	5.4	7.0	8.2	6.4	4.3	15.4	10.5	13.3	14.4	6.6	12.0	5.9	6.7	7.4	32.5	16.2	8.8	8.1	7.6	2.7	6.1	3.1	14.3	4.5	8.8	8.9	5.0	5.7	13.5	8.9	8.8	5.3	5.7	7.6	8.9	2.9	7.8	7.7	3.1	12.6	19.7	5.4	9.5	27.4	6.2	12.7	8.4	4.0	7.0	4.2	8.7	13.4	2.5	9.0	9.3	16.7	7.0	11.5	21.9	14.4	7.1	3.1	5.6	5.0	5.7	14.0	13.9	6.2	14.7	13.6	4.4	13.9	3.9	5.6	3.5	2.9	18.9	3.6	8.4	4.8	7.3	2.4	12.2	3.2	2.9	7.5	12.6	20.3	18.4	23.4	12.4	13.8	11.6	5.8	7.5	7.9	8.9	13.0	3.9	2.8	14.9	4.2	2.4	2.5	2.7	3.4	5.2	2.0	4.4	0.0	6.2	0.4	6.7	10.9	0.0	5.3	7.7	4.6	4.6	3.5	6.2	14.7	0.0	2.4	8.0	15.4	0.9	5.8	15.3	5.0	11.8	4.7	0.9	9.2	5.8	2.1	1.8	4.5	0.0	5.7	7.2	6.8	11.7	10.4	5.3	6.3	3.2
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 291.1;Paneth cells: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.2	2.0	3.6	3.2	1.3	2.3	2.8	2.7	2.6	1.8	9.7	2.6	1.5	10.7	1.7	1.3	3.3	1.6	3.8	0.6	2.8	4.0	2.8	3.4	15.8	2.3	0.7	2.9	1.8	2.9	1.7	1.9	1.8	2.0	4.9	2.2	3.6	1.7	3.2	4.8	3.1	0.9	9.2	17.6	6.3	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	0.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.1	0.4	0.6	1.5	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2	14.9	21.3	6.5	9.8	7.1	24.2	17.9	15.3	4.0	7.9	17.4	27.5	10.2	1.7	6.8	13.4	13.5	291.1	0.0	10.4	8.3	7.1	8.8	6.9	49.5	16.5	17.5	22.4	10.4	25.4	16.4	6.4	15.0	5.0	1.0	70.1	18.1	11.4	112.2	6.3	6.8	21.9	0.0	10.5	25.1	15.9	8.2	13.7	8.5	84.8	18.4
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.3;blood: 68.9;liver: 81.3"	"Cell type enhanced"	"Detected in many"	19	"Early spermatids: 192.0;Hepatocytes: 104.6;Late spermatids: 49.3;Spermatocytes: 45.4;Spermatogonia: 49.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"eosinophil: 26.3;neutrophil: 68.9"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 68.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.3;HDLM-2: 22.0;Hep G2: 22.9;OE19: 44.2"	"Low region specificity"	"Detected in all"							HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	104.3	1.3	1.9	12.5	6.8	1.7	30.4	0.1	4.2	1.0	11.8	0.6	0.4	3.6	0.5	0.6	6.3	0.7	6.3	6.0	1.0	1.2	1.0	81.3	1.8	16.1	0.6	1.2	0.6	1.3	0.4	0.6	0.5	1.0	1.0	1.4	1.2	9.9	0.6	1.3	34.1	8.1	0.9	0.6	3.7	3.3	13.6	0.5	1.0	2.4	3.9	4.5	4.0	2.7	1.5	1.1	68.9	4.2	0.0	0.0	0.9	4.6	2.3	0.1	4.0	30.3	2.4	0.3	0.4	0.5	0.6	0.3	16.7	4.9	7.4	6.2	0.1	4.4	0.1	0.6	2.3	1.6	22.0	0.4	0.5	1.6	22.9	0.3	2.6	2.6	10.1	12.4	2.7	3.9	1.6	0.4	7.5	0.4	10.1	0.2	3.0	1.7	5.7	1.3	44.2	10.9	0.0	0.0	8.7	0.4	12.9	8.3	0.5	4.2	0.7	1.0	1.0	1.6	9.3	0.5	5.3	2.6	0.1	3.2	5.9	13.2	9.9	3.8	8.4	9.0	3.0	4.2	26.3	0.0	0.8	0.0	1.5	0.0	0.0	1.1	1.2	0.0	0.0	68.9	0.0	0.8	0.3	0.0	0.9	1.9	6.8	0.1	4.2	1.0	1.2	0.6	1.2	1.0	0.5	6.0	4.8	3.4	0.8	1.0	0.6	3.4	0.0	1.4	1.2	0.0	2.0	0.5	0.0	1.4	192.0	0.3	0.4	0.0	0.4	0.1	0.8	2.0	0.0	104.6	2.3	1.6	1.2	1.3	5.6	49.3	2.0	1.7	1.7	0.0	5.0	0.5	2.1	2.6	0.7	1.7	0.0	6.5	0.3	45.4	49.4	6.9	0.7	0.0	3.4	4.2
DGKA	"DAGK, DAGK1, DGK-alpha"	ENSG00000065357	"Diacylglycerol kinase alpha"	P23743	12	55927319-55954027	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.1"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 42.2;hTERT-HME1: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041645, HPA045462"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Vesicles	"Nucleoplasm, Mitochondria"	"HPA041645: AB_2677595, HPA045462: AB_2679335"	"unprognostic (1.12e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.66e-5)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.02e-2)"	4.9	4.7	7.1	31.8	8.2	9.7	4.8	6.0	10.8	8.4	13.4	3.6	3.1	20.5	6.9	4.1	42.0	4.9	7.9	3.8	4.6	2.4	3.9	1.5	7.6	28.6	2.1	4.1	4.9	6.4	6.2	3.1	10.2	3.3	10.6	11.0	4.1	16.2	5.3	1.0	33.0	27.2	5.7	3.7	23.1	4.8	4.4	2.6	117.1	4.5	9.6	57.0	13.0	15.1	7.6	4.0	5.4	2.8	5.2	30.2	10.9	6.7	4.3	3.0	4.0	7.5	9.8	0.9	15.2	15.6	6.0	4.4	2.0	11.5	3.8	3.6	10.1	2.0	12.4	3.2	42.2	7.2	3.2	0.7	6.1	9.1	1.1	6.5	1.9	6.0	8.4	22.8	8.3	44.8	20.0	12.2	22.7	0.7	5.9	16.1	0.7	12.5	2.4	0.6	5.6	5.1	5.8	1.0	0.6	14.2	19.5	0.5	1.7	5.0	0.2	0.5	8.2	2.7	2.0	10.9	3.9	2.8	0.8	0.5	0.7	0.3	9.2	4.7	5.2	1.1	5.2	2.8	5.4	6.5	2.0	11.7	7.6	24.3	11.7	4.0	6.4	30.2	18.1	5.2	5.2	1.2	4.0	26.7	10.9	7.1	8.2	6.0	10.8	4.6	2.4	2.1	4.1	3.3	2.6	3.0	6.2	15.6	8.5	13.4	0.8	2.0	0.0	0.0	11.4	5.2	0.0	13.4	0.0	4.1	6.5	3.3	38.4	0.0	8.4	4.0	3.8	8.2	6.9	0.0	3.7	0.0	2.4	4.9	4.1	4.7	3.4	10.2	0.0	16.2	7.5	4.9	15.8	6.2	2.8	0.1	0.4	6.5	3.1	3.8	2.7	12.2	22.1	20.6	5.2	18.0
DGKB	"DAGK2, DGK, DGK-BETA, KIAA0718"	ENSG00000136267	"Diacylglycerol kinase beta"	Q9Y6T7	7	14145049-14974777	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 37.7"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 16.8;Club cells: 3.4;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in single"	11	"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 2.8;fHDF/TERT166: 5.7;hTEC/SVTERT24-B: 2.2;SCLC-21H: 2.9;SH-SY5Y: 2.1;U-266/70: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020321		Supported				NA	NA					"HPA020321: "	"unprognostic (9.89e-2)"	"unprognostic (9.72e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-4)"	1.1	5.2	11.5	1.1	37.7	0.8	0.8	1.3	34.0	4.9	1.6	1.4	0.0	0.9	6.1	0.9	1.6	2.7	1.3	1.4	10.5	4.3	2.6	1.1	0.8	0.8	2.2	11.3	0.8	0.9	0.8	1.8	0.7	4.8	1.1	1.7	0.0	0.9	0.9	1.2	0.9	1.2	3.1	3.5	0.8	0.8	0.9	7.9	0.0	0.9	0.0	0.8	1.5	0.6	0.7	0.6	1.3	0.3	0.6	0.5	0.1	0.1	0.0	2.8	0.1	0.0	0.2	0.1	0.0	1.2	0.0	0.3	0.2	0.0	0.1	0.0	5.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.1	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.9	2.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.0	0.0	0.0	7.6	0.0	0.0	0.1	0.1	0.1	0.7	0.3	0.3	0.5	0.2	0.4	0.3	0.5	0.2	0.1	0.7	0.5	0.4	1.3	0.6	0.2	0.6	0.2	0.1	11.5	37.7	1.3	19.1	10.5	4.3	2.2	11.3	4.8	7.9	0.0	0.0	0.0	0.2	0.1	16.8	1.2	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	1.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.2	6.5	1.4	0.2	0.2	0.4	0.0	0.0	0.0	0.3
DGKD	"DGKdelta, KIAA0145"	ENSG00000077044	"Diacylglycerol kinase delta"	Q16760	2	233354507-233472104	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 22.3;U-698: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027530, HPA049101"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA027530: AB_2672320, HPA049101: AB_2680630"	"unprognostic (1.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.07e-8)"	"unprognostic (1.78e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.94e-3)"	5.9	3.6	10.0	10.9	12.4	26.3	5.3	34.3	7.9	3.7	7.8	8.9	12.4	8.1	5.8	12.6	2.7	5.5	8.0	6.4	9.6	4.3	3.1	3.3	9.3	14.0	11.7	4.3	8.6	3.0	2.3	3.7	8.9	7.2	6.0	8.4	6.2	4.9	8.0	25.4	2.9	10.9	7.3	11.1	10.3	19.4	17.4	8.3	4.5	7.6	1.3	13.5	5.6	10.1	6.6	1.0	5.9	2.0	1.8	3.4	2.5	3.2	8.1	4.7	3.0	2.2	2.2	7.3	1.9	1.7	1.8	1.9	14.0	3.2	5.9	1.0	3.1	12.6	3.3	5.2	2.3	3.0	8.8	4.9	8.2	22.3	4.7	2.8	7.1	8.9	3.1	5.0	2.3	4.5	3.4	2.0	5.7	5.8	1.3	2.0	3.1	5.7	7.4	2.5	6.0	4.6	11.6	8.8	4.7	1.5	3.8	7.3	5.3	6.6	3.6	3.4	3.8	1.5	12.6	1.9	3.9	7.2	2.4	5.9	4.7	3.0	22.6	3.4	11.0	3.1	1.7	2.0	5.9	3.3	0.8	1.6	6.3	1.0	2.9	1.0	6.6	2.3	3.4	2.0	1.8	1.4	0.6	0.5	2.5	10.0	12.4	34.3	7.9	9.6	4.3	11.7	4.3	7.2	8.3	29.8	37.4	31.8	6.6	7.9	25.6	18.6	0.0	6.7	18.2	0.0	58.9	13.3	0.0	3.3	11.9	19.6	32.0	0.0	4.0	0.6	5.8	15.0	5.7	5.4	5.7	7.9	2.4	4.9	15.7	31.1	6.1	9.8	8.5	2.8	25.7	12.8	16.0	12.4	4.2	2.0	45.5	19.4	18.6	14.0	24.0	3.1	2.1	19.2	17.3	7.8
DGKE	"DAGK6, DGK"	ENSG00000153933	"Diacylglycerol kinase epsilon"	P52429	17	56834099-56869567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 167.4;Cone photoreceptor cells: 178.7;Rod photoreceptor cells: 165.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.5;MOLT-4: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017167	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017167: AB_1847638"	"unprognostic (1.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (4.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-3)"	7.8	4.9	7.8	8.3	17.7	5.5	5.2	21.3	18.6	9.5	7.4	4.4	5.6	5.4	13.3	8.9	5.0	8.2	9.4	4.9	7.4	9.2	4.2	4.9	8.1	9.3	5.6	10.0	7.3	6.5	9.5	14.5	5.5	9.9	8.9	7.0	17.4	4.3	7.3	2.4	3.4	7.1	9.3	6.8	12.7	6.4	12.5	5.4	14.5	8.3	2.5	8.6	6.5	15.3	2.4	2.4	1.2	0.8	1.9	4.5	0.8	1.7	1.6	1.5	0.1	0.3	0.5	0.7	2.9	2.3	2.0	2.3	3.8	2.1	2.5	3.6	1.5	1.0	2.1	3.6	1.6	4.1	8.0	4.7	3.2	4.0	2.5	1.7	6.2	4.5	0.9	2.0	2.1	4.2	1.8	2.7	7.4	2.6	43.5	2.4	2.5	14.5	3.5	1.1	2.2	4.9	4.5	6.3	5.9	2.0	3.8	2.4	1.6	2.3	1.2	0.1	1.0	2.7	3.0	2.4	0.5	2.7	0.8	0.4	5.7	11.7	1.7	1.7	3.6	0.1	0.3	0.5	0.0	2.7	0.4	2.0	2.4	1.9	2.3	0.6	0.9	1.9	2.5	1.2	1.9	0.8	2.4	4.5	0.8	7.8	17.7	21.3	18.6	7.4	9.2	5.6	10.0	9.9	5.4	3.0	5.9	2.2	10.2	7.9	167.4	5.5	15.3	1.4	4.5	15.7	178.7	3.2	0.0	6.5	13.1	23.3	3.4	0.0	4.0	2.2	4.3	13.9	0.0	3.8	1.9	7.9	10.9	32.5	5.6	7.4	4.0	4.1	3.3	2.8	7.1	13.8	4.9	5.5	4.9	0.0	165.4	6.5	10.3	25.4	18.5	5.8	2.9	13.8	4.6	8.8
DGKG	DAGK3	ENSG00000058866	"Diacylglycerol kinase gamma"	P49619	3	186105668-186362237	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.4"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 16.2;Ito cells: 27.6;Muller glia cells: 7.5;Sertoli cells: 12.9;Smooth muscle cells: 16.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.2;HL-60: 6.4;U-266/84: 7.7;U-87 MG: 12.8;U-937: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036577	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA036577: AB_10672358"	"unprognostic (2.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.24e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.21e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.05e-7)"	"unprognostic (3.47e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-3)"	3.1	6.9	13.4	3.1	7.1	14.5	1.9	53.4	23.1	2.7	3.5	6.2	1.1	3.0	1.9	14.6	8.5	7.7	2.2	15.0	15.3	7.4	3.1	2.1	4.3	2.1	7.4	11.3	2.0	1.6	4.7	7.5	13.5	25.2	3.1	2.1	7.8	1.9	4.0	2.4	1.4	2.7	5.3	5.6	2.0	3.3	1.2	7.1	0.0	2.5	0.0	2.1	4.8	2.4	0.6	2.9	5.3	4.2	0.0	0.0	1.3	2.7	4.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.4	0.0	2.9	0.2	0.0	0.0	0.0	20.2	0.0	2.7	0.0	2.9	0.0	6.4	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.4	0.3	0.1	0.1	2.2	0.4	0.0	1.2	1.4	0.0	2.3	0.0	0.0	0.5	0.0	0.8	0.0	1.7	0.0	0.1	4.2	0.0	0.0	0.7	2.1	2.4	0.0	7.7	0.0	12.8	6.0	2.3	0.0	4.2	2.4	0.0	2.4	0.0	0.6	0.0	0.0	2.9	0.3	0.0	0.0	5.3	0.0	2.8	0.5	0.0	1.3	13.4	7.1	53.4	14.7	15.3	7.4	7.4	11.3	25.2	7.1	0.0	1.7	1.5	0.1	0.3	0.0	16.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.2	2.4	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.0	0.0	1.9	1.6	0.0	27.6	2.7	2.0	1.7	2.3	0.0	1.0	0.0	7.5	0.7	0.0	0.4	0.8	0.0	12.9	16.7	0.0	0.0	0.4	0.1	0.0	0.0	0.4
DGKH	DGKeta	ENSG00000102780	"Diacylglycerol kinase eta"	Q86XP1	13	42040036-42256578	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 105.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039533, HPA040355, HPA061538"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA039533: AB_10795145, HPA040355: AB_10796452, HPA061538: "	"unprognostic (2.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.55e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.43e-2)"	4.9	2.8	3.3	4.9	12.7	2.3	8.3	9.6	6.2	5.2	6.4	3.4	7.9	3.1	9.4	14.0	5.2	5.9	6.8	10.2	9.0	2.7	6.0	6.8	9.5	4.0	3.5	4.0	4.3	4.2	1.4	3.5	8.9	3.6	4.6	6.9	5.5	7.7	4.8	5.8	6.2	5.1	8.3	3.5	6.1	4.0	7.0	4.3	2.2	4.3	2.0	2.9	8.1	6.0	1.4	1.5	4.3	1.3	0.7	1.7	0.2	4.9	5.8	4.8	3.7	1.8	4.1	0.5	3.2	2.5	2.1	2.6	0.5	4.3	3.9	3.9	3.3	7.4	11.0	4.1	7.1	3.2	3.3	11.5	7.0	3.1	0.4	2.3	2.9	2.0	1.5	7.2	4.0	16.4	3.1	9.4	5.1	2.8	2.7	3.6	4.7	3.0	1.6	1.9	4.8	4.0	4.7	3.9	2.7	7.0	15.0	2.7	2.5	2.9	3.7	2.7	1.9	3.4	8.2	9.1	4.0	3.6	4.3	4.3	1.4	1.3	4.5	2.2	2.7	2.8	2.4	1.3	0.6	1.1	0.9	1.2	0.8	1.7	1.7	0.3	1.4	1.0	1.6	4.3	0.7	0.7	1.5	1.1	0.2	3.3	12.7	9.6	6.2	9.0	2.7	3.5	4.0	3.6	4.3	20.8	28.6	1.9	54.1	54.8	48.5	7.1	25.5	69.6	39.8	10.4	3.9	3.3	1.7	10.6	21.9	28.0	13.6	0.0	6.3	1.8	13.3	64.9	7.0	2.6	5.8	1.6	45.5	27.0	7.5	14.9	3.1	16.5	8.5	9.0	22.6	15.5	17.7	14.4	8.5	7.3	2.2	25.8	35.8	2.3	2.6	29.0	2.4	5.1	18.0	105.9
DGKI	DGK-IOTA	ENSG00000157680	"Diacylglycerol kinase iota"	O75912	7	137381037-137847092	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;thyroid gland: 32.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 40.2;Horizontal cells: 42.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 4.0;GAMG: 4.5;hTEC/SVTERT24-B: 4.2;SCLC-21H: 6.8;U-2197: 18.8;U-87 MG: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.01e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.98e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.73e-3)"	1.5	1.3	5.0	1.1	19.8	0.7	1.1	11.4	12.7	0.8	0.9	2.6	0.0	0.9	1.4	0.9	0.9	0.9	1.9	5.0	4.6	3.3	1.7	0.7	0.8	0.8	2.8	9.0	0.8	0.7	0.8	6.0	0.8	6.6	1.0	0.9	10.8	1.0	1.1	0.7	0.9	0.9	2.7	2.5	0.8	0.8	1.9	5.8	0.0	32.1	0.0	0.8	1.1	0.3	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.0	0.9	0.0	4.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	1.3	4.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.1	0.2	0.0	4.2	0.1	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.8	2.9	0.0	0.0	0.5	0.3	0.0	0.0	0.3	1.6	0.6	18.8	0.9	0.1	0.0	0.0	7.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.0	19.8	11.4	12.7	4.6	3.3	2.8	9.0	6.6	5.8	0.0	0.0	0.0	0.2	1.0	40.2	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	42.9	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.4	0.3	3.0	0.0	1.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0
DGKK		ENSG00000274588	"Diacylglycerol kinase kappa"	Q5KSL6	X	50365409-50470738	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"adrenal gland: 9.8;brain: 29.6;pituitary gland: 33.5"	"Cell type enhanced"	"Detected in single"	20	"Late spermatids: 1.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	6	"gdT-cell: 2.4;memory CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Cell line enriched"	"Detected in some"	19	"Hep G2: 27.9"	"Region enhanced"	"Detected in some"		"hypothalamus: 12.9"	"Group enriched"	"Detected in many"	6	"basal ganglia: 3.5;hypothalamus: 1.8;midbrain: 4.3;pons and medulla: 1.1"							NA	NA						"unprognostic (3.99e-1)"		"unprognostic (1.18e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.23e-1)"		"unprognostic (5.83e-3)"	"unprognostic (9.58e-2)"		"unprognostic (2.41e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.64e-3)"	0.1	9.8	0.0	0.0	29.6	0.2	0.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
DGKQ	"DAGK, DAGK4, DAGK7"	ENSG00000145214	"Diacylglycerol kinase theta"	P52824	4	958887-986895	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 28.3;Paneth cells: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026797, CAB033835"	Uncertain					NA	NA					"CAB033835: AB_2091307, HPA026797: AB_10600902"	"unprognostic (7.39e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.08e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-3)"	6.4	9.3	15.9	10.7	13.8	10.4	6.9	21.6	17.4	5.4	14.7	7.9	6.9	27.0	6.3	3.8	7.9	5.3	10.3	4.5	15.0	12.1	8.4	8.9	6.9	12.3	9.7	12.3	5.1	9.8	5.5	8.2	4.4	10.2	7.0	8.4	6.7	12.1	5.8	3.7	13.0	28.0	5.9	5.2	12.7	8.6	6.8	7.7	9.1	6.7	3.8	8.7	6.6	7.0	1.3	1.9	4.0	1.4	5.3	5.0	1.8	4.2	6.8	3.0	10.0	3.6	3.0	11.1	8.0	4.6	4.6	4.6	4.9	8.4	5.6	6.8	5.1	9.4	4.8	1.7	5.6	1.1	4.4	5.3	8.7	6.3	8.5	6.3	3.7	11.7	5.7	9.6	3.8	1.8	3.9	5.6	11.8	6.5	0.7	3.5	6.3	7.7	21.7	5.3	11.7	11.6	12.5	0.9	0.6	5.0	5.9	1.9	5.1	2.8	3.2	8.4	2.4	7.5	9.1	8.1	8.0	3.8	9.0	5.3	15.5	6.6	4.3	6.9	8.1	7.2	4.0	1.4	2.9	5.0	1.1	2.3	1.1	1.8	4.1	0.9	1.3	1.9	3.4	0.9	5.3	1.1	1.9	1.1	1.8	15.9	13.8	21.6	17.4	15.0	12.1	9.7	12.3	10.2	7.7	3.0	1.9	0.5	1.2	2.5	2.9	2.0	7.6	2.7	1.2	3.5	3.9	0.4	0.0	2.6	0.3	2.8	28.3	0.0	4.2	1.6	2.2	2.1	0.0	4.7	2.2	3.2	7.5	1.8	2.6	0.7	3.7	2.6	3.3	3.6	15.3	2.5	4.1	31.7	2.5	0.9	0.8	0.0	1.6	1.1	5.9	3.3	0.6	7.0	11.1	3.0
DGKZ	"DAGK5, DAGK6, DGK-ZETA, hDGKzeta"	ENSG00000149091	"Diacylglycerol kinase zeta"	Q13574	11	46332905-46380554	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.7"	"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 84.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051336	Enhanced	Supported	Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA051336: AB_2681448"	"unprognostic (2.85e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.66e-3)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.48e-3)"	"unprognostic (7.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.84e-3)"	8.6	6.7	34.5	11.8	27.4	28.0	6.8	22.6	50.7	7.5	7.4	8.5	2.5	21.0	6.1	4.3	7.1	6.3	6.7	16.0	48.0	9.2	5.3	3.3	8.3	20.7	9.4	26.7	5.0	17.3	7.0	18.6	8.4	7.5	5.9	4.2	4.8	24.1	7.0	42.8	8.3	23.2	5.6	7.2	15.6	9.9	5.0	7.5	14.2	4.1	9.1	9.9	7.6	5.0	0.9	12.3	11.2	11.8	7.7	7.5	8.1	11.9	10.7	7.2	10.8	3.8	4.3	33.7	9.3	7.0	9.9	8.7	12.7	5.5	15.4	6.8	9.7	10.9	14.0	8.7	13.5	3.5	15.4	20.3	10.0	7.8	9.3	6.9	18.9	20.3	5.8	6.4	5.4	7.4	5.1	10.9	12.8	14.0	9.5	7.0	31.5	18.2	29.7	21.1	17.3	16.4	21.8	12.6	6.5	3.0	11.7	49.8	8.5	10.7	35.9	7.3	4.8	25.8	23.9	12.2	13.1	14.2	20.6	16.8	6.3	7.1	12.6	17.9	17.2	12.1	11.2	11.8	5.8	7.5	6.1	4.5	0.4	4.7	6.3	12.3	0.9	4.9	5.0	9.8	7.7	5.9	5.9	4.5	8.1	34.5	27.4	22.6	50.7	48.0	9.2	9.4	26.7	7.5	7.5	3.0	10.0	17.1	20.8	11.7	19.2	20.9	10.2	1.4	4.5	8.7	19.6	12.7	8.3	11.4	5.4	22.4	36.9	0.0	41.8	84.0	10.8	14.0	20.7	7.8	43.9	15.9	49.4	57.1	44.7	5.4	12.0	18.5	11.8	19.8	18.9	5.8	26.8	45.6	7.8	15.4	9.2	32.3	11.3	7.0	13.2	8.2	22.9	57.3	18.0	14.7
GNPAT	"DAP-AT, DAPAT, DHAPAT"	ENSG00000116906	"Glyceronephosphate O-acyltransferase"	O15228	1	231241207-231277973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.87e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.29e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-1)"	14.7	20.1	18.3	17.9	17.0	9.6	34.6	18.9	17.8	12.6	18.6	14.7	16.6	18.9	13.9	16.0	14.5	18.4	13.5	39.3	16.9	13.9	16.7	19.5	20.3	24.4	17.1	15.0	15.3	26.7	14.3	15.0	12.3	16.5	15.3	16.3	10.8	20.6	18.0	61.1	14.9	19.1	24.7	17.7	13.5	18.0	26.5	15.0	16.2	13.6	20.2	15.9	14.4	13.6	23.7	23.8	23.4	30.3	16.4	23.9	18.5	14.8	16.6	23.6	17.8	19.4	28.8	15.9	12.6	14.3	13.4	15.4	21.2	18.6	21.4	15.9	18.8	14.1	16.1	15.6	17.1	19.8	24.2	14.3	15.4	16.3	30.5	19.8	26.2	12.3	20.0	21.0	13.8	15.6	17.5	31.3	21.5	22.5	20.6	27.7	4.8	23.3	15.2	37.8	42.2	19.1	25.7	31.6	25.0	16.7	11.1	15.7	22.4	21.1	11.9	18.3	9.8	20.8	41.7	16.3	13.6	12.8	19.6	31.2	26.7	33.9	24.7	19.6	22.2	25.2	17.7	24.1	23.4	16.5	24.0	19.0	23.2	21.6	21.6	23.8	23.7	19.1	17.4	9.5	16.4	30.3	11.3	23.9	18.5	18.3	17.0	18.9	17.8	16.9	13.9	17.1	15.0	16.5	15.0	23.8	14.4	37.4	17.0	11.9	22.4	48.8	28.1	29.4	17.0	26.2	37.3	21.3	14.9	34.5	55.1	21.5	15.8	0.0	37.7	16.2	18.4	21.6	11.5	23.2	24.4	11.1	27.1	16.0	21.2	86.2	23.6	22.5	11.8	25.2	19.8	22.6	34.7	35.1	25.1	22.8	23.3	19.4	22.5	39.6	31.0	12.2	10.4	23.2	31.5	16.0
GPD2		ENSG00000115159	"Glycerol-3-phosphate dehydrogenase 2"	P43304	2	156435290-156613735	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 81.5;Late spermatids: 75.7;Urothelial cells: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 3.1;intermediate monocyte: 3.3;myeloid DC: 5.1;neutrophil: 2.3;non-classical monocyte: 4.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.1;granulocytes: 3.1;monocytes: 6.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008012, HPA045506"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		7600000	Mitochondria		"HPA008012: AB_1079013, HPA045506: AB_2679355"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.01e-2)"	12.7	5.5	19.6	12.4	21.4	11.4	15.2	23.1	16.3	10.9	17.6	8.8	8.1	13.7	9.1	5.0	23.1	18.4	8.6	6.2	18.7	12.7	7.7	3.4	11.4	9.0	11.3	11.8	9.0	7.4	26.6	11.0	7.9	10.3	10.8	17.8	6.8	21.5	7.5	21.2	12.0	24.9	5.9	9.4	10.6	17.1	9.5	8.3	6.7	11.8	17.6	14.0	10.1	10.5	0.5	5.1	3.1	6.5	0.7	0.9	2.7	17.5	11.3	7.1	10.7	14.9	19.0	0.0	22.5	13.8	14.4	17.3	22.2	16.1	3.1	14.6	11.7	5.9	20.2	13.0	20.1	18.4	10.8	4.6	2.6	20.6	0.0	5.2	4.8	5.9	9.0	6.4	24.8	12.4	9.1	10.9	1.6	5.5	0.8	18.0	10.3	0.1	0.4	12.7	6.6	15.0	5.5	4.5	4.1	16.9	22.0	12.6	4.5	20.0	15.1	13.1	11.9	5.1	12.6	10.6	2.8	12.0	12.2	15.8	0.6	0.1	0.1	15.5	1.3	21.5	0.6	6.5	3.1	0.5	3.3	0.9	0.3	0.3	0.9	5.1	0.5	0.7	0.5	2.3	0.7	4.3	0.5	0.9	2.7	19.6	21.4	23.1	16.3	18.7	12.7	11.3	11.8	10.3	8.3	17.9	10.5	5.1	17.9	17.7	4.3	11.3	10.2	10.7	10.3	21.0	5.9	7.0	1.7	8.3	81.5	8.4	22.3	0.0	11.6	12.6	7.8	44.4	12.7	1.8	19.2	4.8	16.7	11.6	14.5	75.7	11.2	13.3	23.6	6.4	14.3	4.3	13.0	20.4	6.7	3.4	9.5	0.0	5.7	1.6	2.0	18.7	9.3	6.9	16.6	62.5
GPIHBP1	"GPI-HBP1, LOC338328"	ENSG00000277494	"Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1"	Q8IV16	8	143213193-143217170	"Disease related genes, Predicted intracellular proteins"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.6;brain: 18.5"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 2: 5.6;Endothelial cells: 23.6;Ito cells: 15.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 8.6"									HPA066302	Enhanced				"Intracellular and membrane"	NA	NA					"HPA066302: AB_2685654"	"unprognostic (2.05e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.75e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.85e-3)"	47.6	2.2	0.0	0.3	11.5	0.1	9.0	0.6	7.5	1.6	1.7	17.9	0.0	0.4	1.6	0.2	2.0	2.2	3.7	8.3	2.1		2.6	0.7	13.0	1.3	18.5	2.9	1.9	0.6	0.3	0.0	4.0	9.7	0.7	0.4	1.1	0.5	1.1	16.0	1.6	0.3	1.5	12.8	4.2	0.4	1.4	10.2	0.0	0.6	0.4	0.7	1.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	5.6	0.0	0.1	1.3	0.0	2.8	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.1	23.6	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	15.4	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.9	0.0	0.2	1.0	0.0	0.0	0.0	0.0
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822245-21937297	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 104.4"	"Cell type enriched"	"Detected in many"	7	"Ito cells: 621.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1700000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	54.8	12.8	1.1	22.9	1.5	0.2	19.8	0.8	1.5	37.3	32.3	2.4	37.2	6.2	62.8	37.6	32.7	20.6	60.0	30.2	1.2	1.2	15.7	8.9	12.5	7.8	2.5	1.2	19.8	9.4	4.6	3.4	24.6	3.8	32.0	2.5	24.6	15.5	22.3	20.8	12.2	13.7	104.4	1.8	16.4	18.9	11.4	0.7	3.4	16.9	20.1	8.5	66.2	28.2	0.2	3.0	0.0	0.0	0.0	0.2	0.0	7.0	6.5	2.2	7.7	22.6	17.2	8.6	10.7	2.7	3.1	2.8	7.9	14.5	0.5	46.8	16.5	0.1	4.4	0.5	5.2	0.7	0.1	0.7	2.4	7.0	5.7	4.7	0.0	0.6	10.4	1.6	3.2	0.9	4.7	103.4	0.0	3.1	0.9	4.2	1.9	0.0	3.2	1.9	3.2	2.9	1.0	9.2	0.9	6.0	0.9	0.2	0.6	8.1	3.4	4.7	2.0	1.3	1.2	82.5	6.1	8.0	4.7	0.3	0.0	1.0	0.4	1.6	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	1.1	1.5	0.8	1.5	1.2	1.2	2.5	1.2	3.8	0.7	65.5	28.7	5.2	10.9	23.5	0.7	4.5	40.8	1.4	12.5	87.2	0.0	9.4	0.0	63.1	1.0	75.0	34.2	0.0	21.9	85.1	58.4	6.6	22.0	2.8	6.1	3.2	2.4	621.2	31.6	2.2	69.6	3.5	57.3	2.8	12.8	1.4	55.1	20.7	65.0	0.5	0.5	32.3	38.8	0.4	4.1	15.6	7.8	6.4	13.9	8.3
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569843	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 91.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 125.3"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;EFO-21: 5.3;Hep G2: 20.0;HMC-1: 5.9;MOLT-4: 4.5;U-2197: 15.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		3200000				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.2	0.1	0.4	1.1	0.7	0.0	0.7	0.1	0.4	0.3	0.2	0.6	0.0	0.7	0.1	0.4	0.2	0.4	0.3	0.3	0.4	0.2	3.0	91.7	0.3	0.2	1.2	0.2	0.3	1.0	0.0	1.0	0.1	1.5	0.3	0.3	0.5	0.1	1.5	0.1	0.3	0.3	0.1	1.2	0.4	0.2	0.1	0.5	2.7	0.5	0.0	0.1	1.1	0.2	0.1	0.2	3.7	0.4	3.0	4.5	2.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.7	0.0	0.0	7.0	0.0	0.0	5.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	20.0	0.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.1	4.5	0.6	0.0	0.0	0.0	0.9	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	15.8	0.0	0.0	0.0	0.1	0.1	0.4	0.0	3.7	0.3	0.0	3.0	0.2	4.5	0.0	0.8	2.2	0.2	0.1	1.0	3.2	0.4	3.0	0.4	0.1	2.1	2.5	0.4	0.7	0.1	0.4	0.4	0.2	1.2	0.2	1.5	0.5	0.0	0.0	5.1	0.0	0.2	0.0	0.8	12.7	0.0	1.2	3.5	0.0	0.0	5.0	3.7	0.0	0.0	0.0	0.0	3.3	0.0	1.2	0.2	0.0	125.3	0.1	0.0	0.0	5.5	4.0	0.0	0.3	0.0	1.7	1.0	0.0	0.0	0.3	0.0	0.0	9.6	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401507-42427426	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Hydrolase	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 207.4;breast: 65.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 123.5;Late spermatids: 188.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"ASC diff: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB017700: AB_2135504, HPA006567: AB_2667618"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	207.4	6.0	3.2	2.9	9.4	2.1	65.1	2.0	6.8	1.2	6.7	19.6	0.8	2.4	1.7	1.3	2.2	1.6	3.6	4.8	6.2	4.2	1.5	1.1	1.4	2.7	18.0	2.3	1.5	2.2	2.2	0.8	1.7	9.9	1.7	1.3	3.7	5.4	1.7	3.7	2.9	3.4	1.7	19.2	3.1	1.6	9.0	10.8	1.7	1.5	1.8	1.9	2.0	3.7	6.1	4.8	10.8	12.1	4.1	5.2	4.0	4.9	3.8	2.5	0.9	57.3	0.5	0.0	2.3	1.3	3.7	3.5	0.9	1.9	8.2	2.6	0.7	1.8	2.2	1.5	4.6	0.4	1.5	2.4	2.3	1.8	0.1	1.1	0.0	5.6	0.5	4.4	0.6	0.8	0.5	1.0	3.4	1.0	5.2	0.5	0.0	5.7	0.2	0.3	3.8	1.1	4.7	0.4	2.7	1.0	5.2	3.5	3.6	2.0	2.3	2.1	0.1	0.6	3.0	1.9	1.0	3.2	0.4	2.1	3.9	3.2	6.1	2.6	0.2	3.5	10.8	12.1	4.7	3.6	6.0	3.3	4.8	4.6	5.2	4.8	6.1	4.1	3.7	2.0	4.1	3.3	3.9	3.9	4.0	3.2	9.4	2.0	6.8	6.2	4.2	18.0	2.3	9.9	10.8	0.0	3.5	1.3	10.1	3.7	8.1	2.2	0.0	0.0	0.0	1.8	9.8	0.0	1.7	6.4	123.5	4.5	3.2	23.3	2.4	0.1	1.7	5.2	0.0	0.0	0.6	7.9	0.0	17.8	1.8	188.1	2.8	1.2	5.0	0.0	1.1	3.3	1.4	0.0	1.4	1.1	12.3	0.0	1.0	26.8	12.4	2.0	0.0	6.9	2.7	9.0
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 762.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.9"	"Cell type enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.4;MOLT-4: 5.0;NTERA-2: 5.3;REH: 3.1;THP-1: 10.0;U-2 OS: 3.6;U-266/70: 4.9"	"Region enriched"	"Detected in single"	51	"olfactory region: 9.9"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.1	1.9	0.1	0.2	28.2	0.1	8.2	0.1	0.1	31.6	0.1	0.6	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	9.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	762.9	0.1	0.1	0.2	0.1	1.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	5.3	0.0	0.0	3.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599182	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.0;placenta: 44.7;thyroid gland: 84.3"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 56.9;Extravillous trophoblasts: 60.0;Hepatocytes: 66.8"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 31.4;HaCaT: 48.1;RPTEC TERT1: 32.0;TIME: 62.4"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 2.1;cerebral cortex: 2.9;hippocampal formation: 1.8;olfactory region: 1.9"	"Low region specificity"	"Detected in many"			HPA016966	Uncertain				"Secreted to blood"	NA	NA	657000000	170000			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	1.5	0.4	0.8	4.7	0.7	0.1	0.8	2.0	0.7	0.4	5.6	3.9	15.0	1.9	0.4	3.1	1.0	0.5	4.3	1.2	1.1	0.9	5.2	37.0	4.4	0.7	1.1	0.1	0.5	1.0	0.0	0.6	44.7	1.4	1.0	2.2	8.3	0.6	24.6	2.6	1.1	7.6	2.2	1.4	0.4	1.4	5.8	0.4	0.3	84.3	2.1	0.5	2.0	0.6	1.2	0.6	2.1	0.6	1.7	0.8	0.1	0.5	0.0	13.8	31.4	0.1	0.0	0.2	0.1	1.4	0.0	0.0	13.6	4.9	0.0	7.6	0.0	9.6	48.1	2.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	1.4	11.1	4.9	9.6	0.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.1	0.0	0.0	0.7	32.0	3.7	0.2	0.0	0.2	0.3	0.0	1.8	0.0	0.0	62.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.4	0.7	0.4	0.4	0.8	0.5	0.5	0.2	1.2	0.8	0.7	2.1	1.7	0.4	0.6	0.4	0.1	0.8	0.7	2.0	0.5	1.1	0.9	1.1	0.1	1.4	0.4	0.0	1.4	0.0	4.8	1.5	0.8	1.7	25.5	0.0	3.4	14.0	56.9	4.7	0.0	3.2	8.0	1.4	9.5	0.0	1.2	60.0	1.0	8.4	0.0	66.8	1.6	0.0	13.3	4.9	1.9	6.0	0.3	0.0	1.7	1.0	3.4	1.0	7.7	2.9	0.0	1.0	2.4	0.0	0.7	1.0	0.8	2.3	16.2	0.7	6.2	9.9
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 482.3;Hofbauer cells: 114.1;Horizontal cells: 195.5;Sertoli cells: 232.8"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Cell line enriched"	"Detected in some"	5	"AF22: 91.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		880000	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	91.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	14.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.4	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4	11.9	93.6	0.0	0.1	1.3	1.0	482.3	0.0	5.3	1.2	0.0	2.0	0.3	13.3	0.0	0.6	5.4	0.0	0.0	0.0	0.6	3.1	0.3	5.8	0.0	114.1	195.5	0.0	4.3	13.4	1.0	1.1	23.8	13.5	2.8	0.0	1.7	0.0	0.0	0.0	0.0	2.2	232.8	19.1	0.3	0.2	0.5	0.3	0.0	0.0	0.1
MGLL	"HU-K5, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-127823250	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 404.8;Pancreatic endocrine cells: 322.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5"	"Cell line enhanced"	"Detected in many"		"BJ: 46.5;BJ hTERT+: 53.6;LHCN-M2: 42.8;RPTEC TERT1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		4300000	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	72.2	6.7	29.4	22.6	29.7	7.5	39.0	32.8	36.9	13.3	36.3	8.3	8.4	16.5	8.7	10.8	63.8	16.3	24.1	35.5	23.6	10.2	22.6	32.1	32.4	6.0	15.4	17.8	3.9	3.6	1.7	5.0	18.9	10.2	10.6	27.6	10.0	31.4	13.6	40.9	11.9	22.3	13.6	12.2	19.2	17.5	3.2	15.5	2.4	6.4	33.4	19.7	14.4	14.5	1.8	30.4	11.6	28.5	0.6	0.9	6.0	11.2	10.1	0.0	0.0	17.8	21.0	1.3	46.5	53.6	10.3	16.6	0.3	4.6	2.9	12.9	15.7	3.1	0.4	0.0	6.1	5.7	5.0	0.1	0.3	7.2	0.0	6.4	0.0	0.3	7.8	3.6	19.3	21.1	5.8	21.8	0.1	0.0	0.5	42.8	1.1	0.0	0.1	0.0	7.3	16.0	0.0	5.5	23.8	38.6	1.2	6.0	0.4	8.0	15.8	2.7	0.4	0.7	0.4	27.9	11.3	3.3	27.2	6.3	0.0	0.0	9.5	23.4	0.6	35.0	4.2	2.8	11.6	0.2	28.5	0.9	1.8	0.2	0.3	3.1	0.2	0.0	0.0	0.5	0.6	18.3	30.4	0.0	6.0	29.4	29.7	32.8	36.9	23.6	10.2	15.4	17.8	10.2	15.5	181.7	90.0	5.2	8.0	20.3	16.7	42.0	119.8	56.2	34.2	40.1	0.0	68.4	142.6	90.3	3.6	101.2	167.0	23.3	144.8	129.8	47.2	9.2	8.1	126.2	122.7	0.0	85.0	14.7	24.4	4.0	30.2	33.6	20.3	404.8	177.1	46.3	322.3	129.8	65.4	60.0	6.1	84.1	176.1	0.2	1.1	19.4	60.8	10.2	49.8	4.2
MOGAT1	"DGAT2L, DGAT2L1, MGAT1"	ENSG00000124003	"Monoacylglycerol O-acyltransferase 1"	Q96PD6	2	222671786-222709930	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"gallbladder: 40.9"	"Cell type enhanced"	"Detected in some"	13	"Cholangiocytes: 5.1;Exocrine glandular cells: 4.5;Hepatocytes: 2.1;Muller glia cells: 2.2"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 3.4"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in single"		"Hep G2: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049944	Uncertain					NA	NA					"HPA049944: AB_2680964"	"unprognostic (6.32e-2)"		"unprognostic (2.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.41e-1)"		"unprognostic (4.28e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-1)"	"unprognostic (9.03e-3)"		2.3	0.1	0.6	0.1	0.5	0.1	1.3	0.2	0.9	0.3	0.6	0.5	0.2	0.0	1.0	1.1	0.5	0.1	40.9	0.8	0.5	0.2	5.7	7.6	1.1	0.3	0.2	0.9	0.1	1.5	2.3	0.4	0.0	0.9	0.2	0.1	0.0	1.4	2.6	0.5	1.6	0.2	0.1	0.3	0.1	1.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.5	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.6	0.5	0.2	0.9	0.5	0.2	0.2	0.9	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	2.2	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
MOGAT2	"DGAT2L5, FLJ22644, MGAT2"	ENSG00000166391	"Monoacylglycerol O-acyltransferase 2"	Q3SYC2	11	75717819-75732958	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 90.2;liver: 40.5"	"Cell type enhanced"	"Detected in some"	19	"Enterocytes: 91.9;Hepatocytes: 64.7;Mucus-secreting cells: 33.4;Undifferentiated cells: 25.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 8.6;RPMI-8226: 5.8"	"Not detected"	"Not detected"							HPA028834	Uncertain					NA	NA					"HPA028834: AB_10601865"	"unprognostic (5.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.15e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.24e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-3)"	0.1	0.0	0.1	4.8	0.1	0.0	2.1	0.1	0.1	0.2	34.0	0.1	1.4	22.3	0.1	0.1	0.2	0.0	2.6	0.1	0.1	0.0	0.2	40.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	7.0	0.1	0.4	2.2	0.4	0.9	90.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.1	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.9	0.0	0.5	0.0	0.0	0.8	0.0	64.7	0.0	0.0	2.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	18.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.1
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201021	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 61.6;liver: 16.0"	"Cell type enhanced"	"Detected in some"	22	"Enterocytes: 76.6;Paneth cells: 56.1;Undifferentiated cells: 21.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.0;liver cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CACO-2: 4.8;Hep G2: 16.2"									HPA011940	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.2	0.1	0.2	2.6	0.2	0.4	0.2	0.2	0.2	0.2	17.3	0.2	0.2	19.7	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.1	0.9	16.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.1	61.6	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.7	1.2	5.3	0.9	1.9	1.2	0.3	0.6	0.2	0.2	0.5	0.0	0.2	0.4	0.6	0.0	0.0	0.0	4.8	1.1	0.4	0.6	0.1	0.6	0.4	0.2	0.1	0.1	0.1	0.2	0.6	0.6	16.2	0.2	0.5	0.6	0.1	0.1	0.0	0.1	0.4	0.1	0.3	0.2	0.7	0.1	0.3	0.3	0.5	0.2	0.5	0.6	0.3	0.1	0.4	0.7	0.6	0.3	0.3	0.3	0.6	0.1	0.8	0.3	0.3	0.8	0.9	0.2	1.0	0.5	0.4	0.2	0.1	1.7	0.6	1.4	2.2	0.9	1.1	1.0	0.7	0.7	1.0	0.8	0.7	0.5	1.7	0.9	1.2	5.3	1.9	0.6	1.2	0.5	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	76.6	0.0	0.0	0.0	0.2	0.2	0.0	5.5	0.0	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.1	56.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	21.5	0.4
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1895	"pancreas: 3207.8"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 3478.1"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;HDLM-2: 2.8;U-2 OS: 4.6;U-251 MG: 1.1;U-266/84: 1.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	NA	NA		13000000			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3207.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.1	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.5	0.0	0.0	0.0	3478.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	25.2	0.0	0.0	826.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PNLIPRP1	PLRP1	ENSG00000187021	"Pancreatic lipase related protein 1"	P54315	10	116590385-116609175	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2629	"pancreas: 516.5"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 576.9"	"Cancer enriched"	"Detected in single"	475	"pancreatic cancer: 32.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"EFO-21: 1.1;U-2 OS: 1.8;U-266/84: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to digestive system"	NA	NA		210000						"unprognostic (1.21e-1)"	"unprognostic (4.08e-3)"						"unprognostic (1.40e-1)"	"unprognostic (1.80e-1)"		"unprognostic (2.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	516.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.0	576.9	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.6	0.1	0.0	108.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427867-116477957	"Enzymes, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 1.0;Late spermatids: 1.6;Melanocytes: 1.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"hTCEpi: 86.9"					"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA046202: AB_10959739, HPA052009: AB_2681692"					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									8.5	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.4	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	8.1	1.9	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.5	8.3	1.7	4.5	65.2	5.8	11.2	11.3	9.1	7.1	6.3	7.1	10.7	6.3	6.7	8.5	4.4	9.5	2.6	4.7	2.2	8.1	23.1	8.7	3.7	11.3	21.4	6.0	11.0	11.4	6.1	4.7	5.5	7.3	5.8	4.7	7.4	6.4	6.3	6.2	8.0	13.1	5.0	10.8	17.9	7.7	3.8	14.1	7.0	2.4	6.4	8.5	21.0	17.9	6.5	1.1	7.7	6.9	10.4	6.4	5.0	4.1	5.1	24.7	15.2	5.3	16.1	8.5	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5	6.0	16.9	27.0	63.2	39.3	8.8	42.3	63.7	5.3	13.6	48.8	7.9	56.2	28.2	55.9	14.2	38.0	114.0	23.3	57.3	27.0	25.2	72.1	11.5	41.9	27.6	11.1	49.4	84.1	28.5	4.2	44.8	24.9	40.5	27.9	80.0	34.7	98.9	112.2	36.7	37.9	7.5	64.7	32.2	42.2	28.2	36.0	141.7	36.2	41.4	167.2
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.5;LHCN-M2: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.3	13.5	5.5	3.8	4.3	0.4	2.4	1.4	3.3	7.2	3.9	7.1	0.0	2.1	4.0	1.9	3.4	8.4	3.9	2.8	0.0	0.7	0.2	3.2	7.2	6.2	0.0	0.2	4.9	3.1	10.6	0.5	5.7	0.4	0.1	0.0	0.0	15.3	0.6	0.2	0.0	9.2	0.4	0.0	0.0	7.3	0.1	1.5	0.2	1.2	0.1	2.7	1.1	3.8	2.4	4.2	4.6	0.4	1.3	4.1	0.1	0.1	0.0	0.0	0.0	11.6	0.0	4.8	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3	0.0	0.0	0.0	0.5	0.3	37.1	1.1	15.3	0.0	0.0	0.0	17.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.0	42.7	0.6	0.0	1.7	0.6	2.6	0.0	0.3	0.0	1.7	0.0	0.5	1.3	1.5	0.0	0.7	5.0	34.3	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.4
PNPLA4	"DXS1283E, GS2, iPLA2eta"	ENSG00000006757	"Patatin like phospholipase domain containing 4"	P41247	X	7898247-7927739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 81.2;Proximal tubular cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003656	Approved				"Intracellular and membrane"	NA	NA					"HPA003656: AB_1079033"	"unprognostic (2.97e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.29e-4)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.23e-12)"	"unprognostic (5.23e-2)"	"unprognostic (6.71e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.12e-1)"	11.3	18.1	12.6	6.0	18.8	4.7	13.9	5.0	11.5	8.9	8.9	8.5	13.3	11.2	9.2	11.4	13.2	15.0	6.2	24.0	10.9	11.9	26.5	39.8	5.8	6.3	12.0	8.7	14.0	21.0	13.3	17.0	4.7	12.2	8.0	7.5	13.1	18.9	10.7	40.9	10.8	10.5	7.4	11.2	5.4	11.5	7.8	10.6	7.2	23.6	21.1	8.9	6.6	9.5	13.2	18.3	7.6	10.4	9.0	10.3	8.4	18.4	7.6	1.2	19.0	0.4	0.2	5.1	5.7	0.6	10.0	6.2	7.6	6.8	5.8	0.0	1.8	0.1	10.9	0.0	19.3	17.1	0.2	13.5	4.1	14.7	15.9	12.7	7.2	6.1	13.0	19.8	5.1	11.9	2.4	6.9	0.2	16.2	0.2	0.1	4.8	0.1	7.2	20.1	12.8	16.1	0.1	0.1	6.4	13.2	8.4	11.0	5.5	17.4	7.2	9.8	22.6	11.2	5.4	3.9	0.1	5.0	15.3	0.1	8.8	0.1	11.0	0.1	0.0	1.6	5.2	9.8	7.6	5.4	10.4	6.2	12.3	7.8	5.9	18.3	13.2	10.3	9.8	0.7	9.0	9.7	13.5	4.8	8.4	12.6	18.8	5.0	11.5	10.9	11.9	12.0	8.7	12.2	10.6	8.9	12.2	10.2	12.9	10.5	11.3	43.9	22.9	26.8	9.1	19.2	0.0	24.2	81.2	29.5	2.3	11.6	26.5	0.0	42.6	18.0	10.3	13.5	8.1	58.6	26.3	9.5	19.0	13.5	7.2	2.2	15.3	11.0	16.9	17.2	30.1	29.0	29.8	28.1	19.1	97.0	12.8	6.5	11.3	15.9	21.3	14.6	11.7	5.2	34.5	13.7
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.2;placenta: 228.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 298.1;Hepatocytes: 520.4;Urothelial cells: 356.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	17	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	40	"B-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 62.1;hTCEpi: 57.5;U-251 MG: 59.2;U-266/70: 61.4;U-266/84: 129.2"	"Group enriched"	"Detected in some"	4	"cerebellum: 10.7;olfactory region: 5.9"	"Not detected"	"Not detected"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	NA	NA	63100000	1600000	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	0.8	3.4	0.5	5.4	0.6	0.0	4.5	0.8	0.7	21.4	18.3	0.5	3.5	14.3	2.3	8.7	103.7	1.6	55.3	0.3	0.4	0.5	68.5	113.2	15.8	6.3	1.9	0.4	1.6	7.0	0.6	0.6	228.8	0.7	13.3	6.2	1.5	16.0	5.2	0.5	69.5	21.9	4.3	0.4	3.7	16.3	2.6	0.4	1.5	3.5	62.3	48.4	30.0	37.7	3.9	0.0	0.0	0.0	0.0	0.0	0.5	31.4	17.6	5.6	14.0	1.5	0.2	17.7	8.8	8.5	8.2	7.0	3.7	19.2	0.0	3.2	6.2	4.5	31.1	2.4	62.1	5.5	0.1	1.6	0.0	1.6	18.8	1.3	1.3	0.1	0.8	57.5	7.4	17.6	11.5	0.9	0.0	0.7	12.3	4.4	18.8	0.0	0.3	5.0	24.0	34.2	0.6	2.0	23.8	10.6	47.2	1.6	13.1	6.6	44.8	2.0	2.3	4.4	0.3	1.3	32.7	10.5	1.2	59.2	61.4	129.2	0.1	9.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.7	0.4	0.5	1.9	0.4	0.7	0.4	86.4	91.4	3.0	135.6	101.2	0.1	0.8	298.1	2.7	63.7	40.1	0.0	2.4	26.6	54.9	0.0	1.1	102.7	23.3	19.0	43.0	9.7	42.4	5.8	520.4	2.2	20.6	10.4	6.7	9.6	0.0	0.6	5.4	20.3	1.0	72.0	0.0	67.3	73.7	1.1	68.3	0.0	0.0	7.1	0.7	12.8	200.1	209.7	4.4	66.5	356.0
